Oral PapersS001: TRANSORAL ROBOTIC SURGERYFOR OROPHARYNGEAL CANCER:LONG TERM QUALITY OF LIFE ANDFUNCTIONAL OUTCOMESPeter T Dziegielewski, MD, FRCSC, K Durmus,MD, T N Teknos, MD, FACS, M Old, MD, FACS,A Agrawal, MD, FACS, K Kakarala, MD, FACS,E Ozer, MD; The Ohio State UniversityObjective: To determine swallowing, speech<strong>and</strong> quality of life (QOL) outcomes followingtransoral robotic surgery for oropharyngealsquamous cell carcinoma (OPSCC).Design: Prospective cohort studySetting: Tertiary care academiccomprehensive cancer centerPatients: 80 consecutive patients withpreviously untreated OPSCCIntervention: Primary surgical resection viatrans-oral robotic surgery (TORS) <strong>and</strong> neckdissection as indicated.Main Outcome Measures: Patients wereasked to complete the <strong>Head</strong> <strong>and</strong> <strong>Neck</strong> CancerInventory (HNCI) pre-operatively <strong>and</strong> at 3weeks as well as 3, 6 <strong>and</strong> 12 months postoperatively.Swallowing ability was assessedby independence from a gastrostomyTube (G-Tube) at the same time points.Demographic, pathological <strong>and</strong> follow-updata were also collected. Factors predicitve ofa lower quality of life were identified with amultivariate analysis.Results: The median follow-up time was18.3 months. The HNCI response rates at 3weeks <strong>and</strong> 3, 6, <strong>and</strong> 12 months were 80%,80%, 63%, 54% respectively. There wereoverall declines in eating, aesthetic, social<strong>and</strong> overall QOL domains in the early postoperativeperiods. However, at 1 year afterTORS scores for aesthetic, social <strong>and</strong> overallQOL remained high. Speech scores remainedhigh throughout time periods. T-classification,N-Classification, age <strong>and</strong> post-operativeradiation/chemotherapy correlated with lowerQOL (p
Oral Paperssignificantly shorter for patients initiallyclosed with either flap technique comparedto primary closure. Onlay or interposed flapclosure to reduce incidence <strong>and</strong> severity offistula should be considered when performingsalvage laryngectomy.S003: SO-CALLED TOTALTHYROIDECTOMY: MEASURING THEEXTENT OF THYROID SURGERY WITH RAIJuntian Lang, MD, , PhD, Uma Ramaswamy,Eric Rohren, MD, Naifa L Bussaidy, MD,Maria E Cabanillas, MD, R<strong>and</strong>al S Weber, MD,FACS, Christopher F Holsinger, MD, FACS;The University of Texas MD Anderson CancerCenterObjective: To investigate the rate of patientswith or without thyroid remnant <strong>and</strong> therelationship between postoperative stimulatedthyroglobulin(Tg) level <strong>and</strong> thyroid remnantsafter total thyroidectomy for patients withdifferentiated thyroid carcinoma.Patients <strong>and</strong> Methods: We evaluatedpatients undergoing total thyroidectomy atMD Anderson Cancer Center from 01/01/2001to 02/20/2012 for T1-3N0M0 differentiatedthyroid cancer (DTC) who received diagnosticpost-operative radioactive iodine imaging.Two hundred <strong>and</strong> twenty-nine patients hadquantitated uptake on RAI imaging <strong>and</strong> wereincluded in this study. Based on the calculationof I123 background signal, radioactive iodineuptake of 0.2% was taken as the cut-off ofpresence or absence of thyroid remnant.Average time to last follow-up was 45.2months.Results: Ninty-three patients (40.6%) withuptake of radioactive iodine less than 0.2% onpost-operative imaging suggesting that a totalthyroidectomy was performed. The remaining136 patients demonstrated some measurableiodine-avid thyroid tissue <strong>and</strong>/or tumor in thethyroid bed (112; 82.4%), the neck (6; 4.4%)or both (17, 12.5%). For those patients withpositive iodine signal, the average 24-houriodine uptake was 1.1% (0.2-7.0%). For theentire study population (229 pts), average 24-hour iodine uptake was 0.67%. Measurable Tg(≥1ng/ml) was found in 19/93 (20.4%) patientswithout thyroid remnant <strong>and</strong> in 82/136 (60.3%)(x2=38.5, p=0.000) with thyroid remnant. Therewere five recurrences (2%), three of whichwere RAIU positive, <strong>and</strong> two patients showedno postoperative thyroid remnant. One patientwith RAI proven thyroid remnant died ofdisease.Conclusion: One hundred <strong>and</strong> thirty-six of229(59.4%) DTC patients had residual thyroidtissue after total thyroidectomy. The rate ofdetectable Tg in thyroid remnant positivegroup is higher than that of thyroid remnantnegative group (60.3% vs. 20.4%, p=0.000).S004: DONOR SITE MORBIDITYIN ELDERLY PATIENTS AFTERFASCIOCUTANEOUS FREE TISSUETRANSFERJacob L Wester, BS, Amy Pittman, MD, RobertH Lindau, MD, Mark K Wax, MD; Oregon Health<strong>and</strong> Science UniversityObjectives: Several studies have shownexcellent reconstructive outcomes usingfree tissue transfer in elderly patients. Thesestudies, however, are limited in size <strong>and</strong> fewdescribe long term donor site morbidity. Thepurpose of our study is to assess donor sitemorbidity after fasciocutaneous free tissuetransfer in patients 70 years <strong>and</strong> older.Methods: Patients were identified from2002-2011 at a tertiary-care center who wereover 70 years of age <strong>and</strong> had fasciocutaneousfree flap reconstruction of the head <strong>and</strong> neck.Donor sites included; radial forearm (RFFF),ulnar forearm (UFFF) <strong>and</strong> anterolateral thigh(ALT). 171 younger patients from the sametime period were r<strong>and</strong>omly selected to act ascontrols. Demographic, surgical <strong>and</strong> clinicaldata were extracted from the electronicmedical record. Donor site morbidity wascompared between the two groups.Results: 622 fasciocutaneous free flapswere performed during the study period. 158(25.4%) flaps were performed on patients 70years <strong>and</strong> older, with a median age of 77 years(70-92). There were 100 RFFF, 9 UFFF, <strong>and</strong> 49ALT flaps performed. The median paddle sizewas 64 cm2 <strong>and</strong> median follow up time was10 months. Overall donor site morbidity inpatients 70 years <strong>and</strong> older was 22.2% vs.25.2% in patients less than 70 years, p=0.6.Infection was the most common morbidity inthe elderly (8.9%) <strong>and</strong> was not significantlydifferent from younger patients (9.4%),p=0.84. Complete loss of STSG (6.2% vs. 2.9%,p=0.34), forearm tendon exposure (7.1% vs.3.9%, p=0.38), extremity numbness (4.7% vs.3.2%, p=0.57) <strong>and</strong> seroma (5.2% vs. 2.5%,p=0.26) were not significantly different.Conclusion: Donor site morbidity maybe expected in up to 1 of 4 patients afterfasciocutaneous free tissue transfer. Age over70 years does not increase this risk.S005: USE OF THE SUPRACLAVICULARARTERY ISLAND FLAP IN HEAD ANDNECK ONCOLOGIC RECONSTRUCTION:APPLICATIONS AND LIMITATIONSNiels Kokot, MD, Grace Peng, MD, KashifMazhar, MD, Lindsay Reder, MD, UttamK Sinha, MD; Keck School of Medicine,University of Southern CaliforniaObjective: Free tissue transfer has becomethe st<strong>and</strong>ard of care for head <strong>and</strong> neckreconstruction in academic medical centers.The radial forearm free flap (RFFF) <strong>and</strong>anterolateral thigh (ALT) free flap are twoworkhorse flaps for soft tissue reconstruction.The supraclavicular artery isl<strong>and</strong> (SAI) flap isa local rotational flap that has been describedas an alternative to free tissue transfer inhead <strong>and</strong> neck reconstruction. We previouslypresented our initial experience using the SAIflap. The purpose of this study is to present ourcurrently larger experience using the SAI flap,including some of its limitations.Methods: Retrospective chart review of ourfirst 45 consecutive patients who underwentreconstruction with SAI flap following head<strong>and</strong> neck oncologic surgery was done, afterobtaining IRB approval. Information onprior treatment, size <strong>and</strong> location of defect,time required to raise the flap, time to deepithelializethe flap, flap viability, donor sitemorbidity, <strong>and</strong> complications was collected. Allstatistical analysis was done using SAS 9.1.Results: 38 out of 45 patients underwentablative surgery for head <strong>and</strong> neck carcinoma50 <strong>AHNS</strong> <strong>2013</strong> <strong>Annual</strong> <strong>Meeting</strong>
- Page 4 and 5: Table of Contents6 General Informat
- Page 6 and 7: JW Marriott Grande Lakes FloorplanS
- Page 8 and 9: About the American Head and Neck So
- Page 10 and 11: AHNS Audience Response Instructions
- Page 12 and 13: 2013 Program ChairEben L. Rosenthal
- Page 14 and 15: Hayes Martin LecturerJonas T. Johns
- Page 16 and 17: John J. Conley LecturerPatrick J. G
- Page 18 and 19: Jatin P. Shah Symposium & Biography
- Page 20 and 21: Distinguished Service AwardDennis H
- Page 22 and 23: Presidential CitationsNeal D. Futra
- Page 24 and 25: Congratulations to theAHNS 2013 Awa
- Page 26 and 27: AHNS LeadershipConstitution and By-
- Page 28 and 29: AHNS LeadershipQuality of Care Comm
- Page 30: Robert Maxwell Byers BiographyRober
- Page 33 and 34: CME WorksheetThis is not your CME c
- Page 35: Commercial Bias Reporting FormYou a
- Page 38 and 39: Scientific Program Wednesday, April
- Page 40 and 41: Scientific Program Wednesday, April
- Page 42 and 43: Scientific Session Thursday, April
- Page 44 and 45: Scientific Session Thursday, April
- Page 46 and 47: Faculty ListingNishant Agarwal, MD
- Page 50 and 51: Oral Papersand had a SAI flap perfo
- Page 52 and 53: Oral PapersS009: A COMPARISON OF OU
- Page 54 and 55: Oral PapersS012: ROBOT-ASSISTEDCOMP
- Page 56 and 57: Oral Papersoncologic outcome of the
- Page 58 and 59: Oral Paperscontrol, as noted on uni
- Page 60 and 61: Oral Papersrates in Whites, Blacks
- Page 62 and 63: Oral Papersthat was able to be remo
- Page 64 and 65: Oral Papersproportional hazards mod
- Page 66 and 67: Poster ListingP001 (COSM Poster #05
- Page 68 and 69: Poster ListingP028 (COSM Poster #07
- Page 70 and 71: Poster ListingP054 (COSM Poster #10
- Page 72 and 73: Poster ListingP083 (COSM Poster #13
- Page 74 and 75: Poster ListingP112 (COSM Poster #16
- Page 76 and 77: Poster ListingP143 (COSM Poster #19
- Page 78 and 79: AHNS 2013 New MembersThe AHNS exten
- Page 80 and 81: Certificate of Incorporation5. Noth
- Page 82 and 83: Constitutionof the American College
- Page 84 and 85: BylawsArticle IVOrder of BusinessSe
- Page 86 and 87: BylawsSection 2. Duties of the Vice
- Page 88 and 89: BylawsSection 2. Scientific Program
- Page 90 and 91: BylawsSection 16. Awards Committee.
- Page 92 and 93: Bylawssuit or proceeding in which t
- Page 94 and 95: NotesApril 10 - 11, 2013 · www.ahn
- Page 96 and 97: NotesApril 10 - 11, 2013 · www.ahn
- Page 98 and 99:
NotesApril 10 - 11, 2013 · www.ahn